|
|
||||||||
The Journal of Immunology, Vol 149, Issue 1 175-180, Copyright © 1992 by American Association of Immunologists
ARTICLES |
R Gazzinelli, Y Xu, S Hieny, A Cheever and A Sher
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
C57BL/6 mice chronically infected with an avirulent strain (ME-49) of Toxoplasma gondii were used to study the mechanisms by which T lymphocytes and IFN-gamma prevent reactivation of latent infection. Infected animals were treated with mAb, either anti-CD8, anti-CD4, anti- CD4 plus anti-CD8, anti-IFN-gamma, or anti-CD4 plus anti-IFN-gamma and the mice followed for survival, histopathology, cyst numbers, and spleen cell cytokine responses. In agreement with previously published findings, treatment with anti-IFN-gamma antibodies fully reactivated the asymptomatic infection, inducing massive necrotic areas in the brain with the appearance of free tachyzoites and death of all animals within 2 wk. Mice treated with the combination of anti-CD4 plus anti- CD8 antibodies showed augmented pathology and mortality nearly identical to the anti-IFN-gamma- treated animals. In contrast, treatment with anti-CD4 or anti-CD8 mAb alone failed to result in significantly enhanced brain pathology or mortality. In additional experiments, full reactivation of infection was observed in mice treated with anti-CD4 plus anti-IFN-gamma indicating that CD4+ lymphocytes are not required for the pathology resulting from IFN-gamma neutralization. Cytokine measurements on parasite Ag-stimulated spleen cells from mAb-treated mice indicated that both CD4+ and CD8+ cells produce IFN-gamma whereas only CD4+ cells contribute to parasite Ag- induced IL-2 synthesis. Together, these results suggest that CD4+ and CD8+ lymphocytes act additively or synergistically to prevent reactivation of chronic T. gondii infection probably through the production of IFN-gamma.
This article has been cited by other articles:
![]() |
J. P. Gigley, B. A. Fox, and D. J. Bzik Long-Term Immunity to Lethal Acute or Chronic Type II Toxoplasma gondii Infection Is Effectively Induced in Genetically Susceptible C57BL/6 Mice by Immunization with an Attenuated Type I Vaccine Strain Infect. Immun., December 1, 2009; 77(12): 5380 - 5388. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Ju, A. Chockalingam, and C. A. Leifer Early Response of Mucosal Epithelial Cells during Toxoplasma gondii Infection J. Immunol., December 1, 2009; 183(11): 7420 - 7427. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Jordan, E. H. Wilson, E. D. Tait, B. A. Fox, D. S. Roos, D. J. Bzik, F. Dzierszinski, and C. A. Hunter Kinetics and Phenotype of Vaccine-Induced CD8+ T-Cell Responses to Toxoplasma gondii Infect. Immun., September 1, 2009; 77(9): 3894 - 3901. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. la Sala, J. He, L. Laricchia-Robbio, S. Gorini, A. Iwasaki, M. Braun, G. S. Yap, A. Sher, K. Ozato, and B. Kelsall Cholera toxin inhibits IL-12 production and CD8{alpha}+ dendritic cell differentiation by cAMP-mediated inhibition of IRF8 function J. Exp. Med., June 8, 2009; 206(6): 1227 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schaeffer, S.-J. Han, T. Chtanova, G. G. van Dooren, P. Herzmark, Y. Chen, B. Roysam, B. Striepen, and E. A. Robey Dynamic Imaging of T Cell-Parasite Interactions in the Brains of Mice Chronically Infected with Toxoplasma gondii J. Immunol., May 15, 2009; 182(10): 6379 - 6393. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Couper, P. A. Lanthier, G. Perona-Wright, L. W. Kummer, W. Chen, S. T. Smiley, M. Mohrs, and L. L. Johnson Anti-CD25 Antibody-Mediated Depletion of Effector T Cell Populations Enhances Susceptibility of Mice to Acute but Not Chronic Toxoplasma gondii Infection J. Immunol., April 1, 2009; 182(7): 3985 - 3994. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Persson, H. Lambert, P. P. Vutova, I. Dellacasa-Lindberg, J. Nederby, H. Yagita, H.-G. Ljunggren, A. Grandien, A. Barragan, and B. J. Chambers Transmission of Toxoplasma gondii from Infected Dendritic Cells to Natural Killer Cells Infect. Immun., March 1, 2009; 77(3): 970 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Gigley, B. A. Fox, and D. J. Bzik Cell-Mediated Immunity to Toxoplasma gondii Develops Primarily by Local Th1 Host Immune Responses in the Absence of Parasite Replication J. Immunol., January 15, 2009; 182(2): 1069 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Benevides, C. M. Milanezi, L. M. Yamauchi, C. F. Benjamim, J. S. Silva, and N. M. Silva CCR2 Receptor Is Essential to Activate Microbicidal Mechanisms to Control Toxoplasma gondii Infection in the Central Nervous System Am. J. Pathol., September 1, 2008; 173(3): 741 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Drogemuller, U. Helmuth, A. Brunn, M. Sakowicz-Burkiewicz, D. H. Gutmann, W. Mueller, M. Deckert, and D. Schluter Astrocyte gp130 Expression Is Critical for the Control of Toxoplasma Encephalitis J. Immunol., August 15, 2008; 181(4): 2683 - 2693. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Wilson, S. Matthews, and G. S. Yap IL-12 Signaling Drives CD8+ T Cell IFN-{gamma} Production and Differentiation of KLRG1+ Effector Subpopulations during Toxoplasma gondii Infection J. Immunol., May 1, 2008; 180(9): 5935 - 5945. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Khan, R. Hakak, K. Eberle, P. Sayles, L. M. Weiss, and J. F. Urban Jr. Coinfection with Heligmosomoides polygyrus Fails To Establish CD8+ T-Cell Immunity against Toxoplasma gondii Infect. Immun., March 1, 2008; 76(3): 1305 - 1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Goldszmid, A. Bafica, D. Jankovic, C. G. Feng, P. Caspar, R. Winkler-Pickett, G. Trinchieri, and A. Sher TAP-1 indirectly regulates CD4+ T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-{gamma} production J. Exp. Med., October 29, 2007; 204(11): 2591 - 2602. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. B. Carruthers and Y. Suzuki Effects of Toxoplasma gondii Infection on the Brain Schizophr Bull, May 1, 2007; 33(3): 745 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Masek, J. Fiore, M. Leitges, S.-F. Yan, B. D. Freedman, and C. A. Hunter Host cell Ca2+ and protein kinase C regulate innate recognition of Toxoplasma gondii J. Cell Sci., November 1, 2006; 119(21): 4565 - 4573. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lutjen, S. Soltek, S. Virna, M. Deckert, and D. Schluter Organ- and Disease-Stage-Specific Regulation of Toxoplasma gondii-Specific CD8-T-Cell Responses by CD4 T Cells. Infect. Immun., October 1, 2006; 74(10): 5790 - 5801. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Allen and G. S. Deepe Jr. B Cells and CD4-CD8- T Cells Are Key Regulators of the Severity of Reactivation Histoplasmosis J. Immunol., August 1, 2006; 177(3): 1763 - 1771. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Combe, M. M. Moretto, J. D. Schwartzman, J. P. Gigley, D. J. Bzik, and I. A. Khan Lack of IL-15 results in the suboptimal priming of CD4+ T cell response against an intracellular parasite PNAS, April 25, 2006; 103(17): 6635 - 6640. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Suffia, S. K. Reckling, C. A. Piccirillo, R. S. Goldszmid, and Y. Belkaid Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens J. Exp. Med., March 20, 2006; 203(3): 777 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Egan, J. E. Dalton, E. M. Andrew, J. E. Smith, M.-J. Gubbels, B. Striepen, and S. R. Carding A Requirement for the V{gamma}1+ Subset of Peripheral {gamma}{delta} T Cells in the Control of the Systemic Growth of Toxoplasma gondii and Infection-Induced Pathology J. Immunol., December 15, 2005; 175(12): 8191 - 8199. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Couper, C. W. Roberts, F. Brombacher, J. Alexander, and L. L. Johnson Toxoplasma gondii-Specific Immunoglobulin M Limits Parasite Dissemination by Preventing Host Cell Invasion Infect. Immun., December 1, 2005; 73(12): 8060 - 8068. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Combe, T. J. Curiel, M. M. Moretto, and I. A. Khan NK Cells Help To Induce CD8+-T-Cell Immunity against Toxoplasma gondii in the Absence of CD4+ T Cells Infect. Immun., August 1, 2005; 73(8): 4913 - 4921. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Smiley, P. A. Lanthier, K. N. Couper, F. M. Szaba, J. E. Boyson, W. Chen, and L. L. Johnson Exacerbated Susceptibility to Infection-Stimulated Immunopathology in CD1d-Deficient Mice J. Immunol., June 15, 2005; 174(12): 7904 - 7911. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Gubbels, B. Striepen, N. Shastri, M. Turkoz, and E. A. Robey Class I Major Histocompatibility Complex Presentation of Antigens That Escape from the Parasitophorous Vacuole of Toxoplasma gondii Infect. Immun., February 1, 2005; 73(2): 703 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Portugal, L. R. Fernandes, G. C. Cesar, H. C. Santiago, D. R. Oliveira, N. M. Silva, A. A. Silva, J. Lannes-Vieira, R. M. E. Arantes, R. T. Gazzinelli, et al. Infection with Toxoplasma gondii Increases Atherosclerotic Lesion in ApoE-Deficient Mice Infect. Immun., June 1, 2004; 72(6): 3571 - 3576. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fux, C. V. Rodrigues, R. W. Portela, N. M. Silva, C. Su, D. Sibley, R. W. A. Vitor, and R. T. Gazzinelli Role of Cytokines and Major Histocompatibility Complex Restriction in Mouse Resistance to Infection with a Natural Recombinant Strain (Type I-III) of Toxoplasma gondii Infect. Immun., November 1, 2003; 71(11): 6392 - 6401. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Nguyen, G. Bigaignon, D. Markine-Goriaynoff, H. Heremans, T. N. Nguyen, G. Warnier, M. Delmee, M. Warny, S. F. Wolf, C. Uyttenhove, et al. Virulent Toxoplasma gondii strain RH promotes T-cell-independent overproduction of proinflammatory cytokines IL12 and {gamma}-interferon J. Med. Microbiol., October 1, 2003; 52(10): 869 - 876. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Robbins, S. C. Terrizzi, B. C. Sydora, T. Mikayama, and L. Brossay Differential Regulation of Killer Cell Lectin-Like Receptor G1 Expression on T Cells J. Immunol., June 15, 2003; 170(12): 5876 - 5885. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Schluter, L.-Y. Kwok, S. Lutjen, S. Soltek, S. Hoffmann, H. Korner, and M. Deckert Both Lymphotoxin-{alpha} and TNF Are Crucial for Control of Toxoplasma gondii in the Central Nervous System J. Immunol., June 15, 2003; 170(12): 6172 - 6182. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-Y. Kwok, S. Lutjen, S. Soltek, D. Soldati, D. Busch, M. Deckert, and D. Schluter The Induction and Kinetics of Antigen-Specific CD8 T Cells Are Defined by the Stage Specificity and Compartmentalization of the Antigen in Murine Toxoplasmosis J. Immunol., February 15, 2003; 170(4): 1949 - 1957. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Scorza, S. D'Souza, M. Laloup, J. Dewit, J. De Braekeleer, H. Verschueren, M. Vercammen, K. Huygen, and E. Jongert A GRA1 DNA Vaccine Primes Cytolytic CD8+ T Cells To Control Acute Toxoplasma gondii Infection Infect. Immun., January 1, 2003; 71(1): 309 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Villegas, L. A. Lieberman, N. Mason, S. L. Blass, V. P. Zediak, R. Peach, T. Horan, S. Yoshinaga, and C. A. Hunter A Role for Inducible Costimulator Protein in the CD28- Independent Mechanism of Resistance to Toxoplasma gondii J. Immunol., July 15, 2002; 169(2): 937 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Schluter, T. Meyer, L.-Y. Kwok, M. Montesinos-Rongen, S. Lutjen, A. Strack, M. L. Schmitz, and M. Deckert Phenotype and Regulation of Persistent Intracerebral T Cells in Murine Toxoplasma Encephalitis J. Immunol., July 1, 2002; 169(1): 315 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Khan, M. Moretto, X.-q. Wei, M. Williams, J. D. Schwartzman, and F. Y. Liew Treatment with Soluble Interleukin-15R{alpha} Exacerbates Intracellular Parasitic Infection by Blocking the Development of Memory CD8+ T Cell Response J. Exp. Med., June 3, 2002; 195(11): 1463 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Casciotti, K. H. Ely, M. E. Williams, and I. A. Khan CD8+-T-Cell Immunity against Toxoplasma gondii Can Be Induced but Not Maintained in Mice Lacking Conventional CD4+ T Cells Infect. Immun., February 1, 2002; 70(2): 434 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Johnson and P. C. Sayles Deficient Humoral Responses Underlie Susceptibility to Toxoplasma gondii in CD4-Deficient Mice Infect. Immun., January 1, 2002; 70(1): 185 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Butcher, L. Kim, P. F. Johnson, and E. Y. Denkers Toxoplasma gondii Tachyzoites Inhibit Proinflammatory Cytokine Induction in Infected Macrophages by Preventing Nuclear Translocation of the Transcription Factor NF-{kappa}B J. Immunol., August 15, 2001; 167(4): 2193 - 2201. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Shen, D. M. Matteson, N. Tuaillon, B. K. Suedekum, R. R. Buggage, and C.-C. Chan Involvement of Apoptosis and Interferon-{gamma} in Murine Toxoplasmosis Invest. Ophthalmol. Vis. Sci., August 1, 2001; 42(9): 2031 - 2036. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Gavrilescu and E. Y. Denkers IFN-{{gamma}} Overproduction and High Level Apoptosis Are Associated with High but Not Low Virulence Toxoplasma gondii Infection J. Immunol., July 15, 2001; 167(2): 902 - 909. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nishikawa, K. Tragoolpua, N. Inoue, L. Makala, H. Nagasawa, H. Otsuka, and T. Mikami In the Absence of Endogenous Gamma Interferon, Mice Acutely Infected with Neospora caninum Succumb to a Lethal Immune Response Characterized by Inactivation of Peritoneal Macrophages Clin. Vaccine Immunol., July 1, 2001; 8(4): 811 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Roberts, W. Walker, and J. Alexander Sex-Associated Hormones and Immunity to Protozoan Parasites Clin. Microbiol. Rev., July 1, 2001; 14(3): 476 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bonenfant, I. Dimier-Poisson, F. Velge-Roussel, D. Buzoni-Gatel, G. Del Giudice, R. Rappuoli, and D. Bout Intranasal Immunization with SAG1 and Nontoxic Mutant Heat-Labile Enterotoxins Protects Mice against Toxoplasma gondii Infect. Immun., March 1, 2001; 69(3): 1605 - 1612. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. R. Freund, N. T. Zaveri, and H. S. Javitz In Vitro Investigation of Host Resistance to Toxoplasma gondii Infection in Microglia of BALB/c and CBA/Ca Mice Infect. Immun., February 1, 2001; 69(2): 765 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Khan, P. M. Murphy, L. Casciotti, J. D. Schwartzman, J. Collins, J.-L. Gao, and G. R. Yeaman Mice Lacking the Chemokine Receptor CCR1 Show Increased Susceptibility to Toxoplasma gondii Infection J. Immunol., February 1, 2001; 166(3): 1930 - 1937. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moretto, L. Casciotti, B. Durell, and I. A. Khan Lack of CD4+ T Cells Does Not Affect Induction of CD8+ T-Cell Immunity against Encephalitozoon cuniculi Infection Infect. Immun., November 1, 2000; 68(11): 6223 - 6232. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. King, D. S. Lindsay, M. F. Ehrich, and M. Nagarkatti Effect of 2,3,7,8-Tetrachloro-di-benzo-p-dioxin on T Cell Subpopulations in the Thymus and Spleen of Mice with Chronic Toxoplasma gondii Infection International Journal of Toxicology, September 1, 2000; 19(5): 323 - 329. [Abstract] [PDF] |
||||
![]() |
G. Cai, T. Radzanowski, E. N. Villegas, R. Kastelein, and C. A. Hunter Identification of STAT4-Dependent and Independent Mechanisms of Resistance to Toxoplasma gondii J. Immunol., September 1, 2000; 165(5): 2619 - 2627. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-G. Fischer, U. Bonifas, and G. Reichmann Phenotype and Functions of Brain Dendritic Cells Emerging During Chronic Infection of Mice with Toxoplasma gondii J. Immunol., May 1, 2000; 164(9): 4826 - 4834. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Prigione, P. Facchetti, L. Lecordier, D. Deslee, S. Chiesa, M.-F. Cesbron-Delauw, and V. Pistoia T Cell Clones Raised from Chronically Infected Healthy Humans by Stimulation with Toxoplasma gondii Excretory-Secretory Antigens Cross-React with Live Tachyzoites: Characterization of the Fine Antigenic Specificity of the Clones and Implications for Vaccine Development J. Immunol., April 1, 2000; 164(7): 3741 - 3748. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Sayles, G. W. Gibson, and L. L. Johnson B Cells Are Essential for Vaccination-Induced Resistance to Virulent Toxoplasma gondii Infect. Immun., March 1, 2000; 68(3): 1026 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kang, J. S. Remington, and Y. Suzuki Decreased Resistance of B Cell-Deficient Mice to Infection with Toxoplasma gondii Despite Unimpaired Expression of IFN-{gamma}, TNF-{alpha}, and Inducible Nitric Oxide Synthase J. Immunol., March 1, 2000; 164(5): 2629 - 2634. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. V. Nielsen, S. L. Lauemoller, L. Christiansen, S. Buus, A. Fomsgaard, and E. Petersen Complete Protection against Lethal Toxoplasma gondii Infection in Mice Immunized with a Plasmid Encoding the SAG1 Gene Infect. Immun., December 1, 1999; 67(12): 6358 - 6363. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Khan, W. R. Green, L. H. Kasper, K. A. Green, and J. D. Schwartzman Immune CD8+ T Cells Prevent Reactivation of Toxoplasma gondii Infection in the Immunocompromised Host Infect. Immun., November 1, 1999; 67(11): 5869 - 5876. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Khan and L. Casciotti IL-15 Prolongs the Duration of CD8+ T Cell-Mediated Immunity in Mice Infected with a Vaccine Strain of Toxoplasma gondii J. Immunol., October 15, 1999; 163(8): 4503 - 4509. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Villegas, M. M. Elloso, G. Reichmann, R. Peach, and C. A. Hunter Role of CD28 in the Generation of Effector and Memory Responses Required for Resistance to Toxoplasma gondii J. Immunol., September 15, 1999; 163(6): 3344 - 3353. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Reichmann, E. N. Villegas, L. Craig, R. Peach, and C. A. Hunter The CD28/B7 Interaction Is Not Required for Resistance to Toxoplasma gondii in the Brain but Contributes to the Development of Immunopathology J. Immunol., September 15, 1999; 163(6): 3354 - 3362. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Doherty, C. Chougnet, M. Schito, B. K. Patterson, C. Fox, G. M. Shearer, G. Englund, and A. Sher Infection of HIV-1 Transgenic Mice with Mycobacterium avium Induces the Expression of Infectious Virus Selectively from a Mac-1-Positive Host Cell Population J. Immunol., August 1, 1999; 163(3): 1506 - 1515. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Yap and A. Sher Effector Cells of Both Nonhemopoietic and Hemopoietic Origin Are Required for Interferon (IFN)-{gamma}- and Tumor Necrosis Factor (TNF)-{alpha}-dependent Host Resistance to the Intracellular Pathogen, Toxoplasma gondii J. Exp. Med., April 5, 1999; 189(7): 1083 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Denney, L. Eckmann, and S. L. Reed Chemokine Secretion of Human Cells in Response to Toxoplasma gondii Infection Infect. Immun., April 1, 1999; 67(4): 1547 - 1552. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Schluter, M. Deckert-Schluter, E. Lorenz, T. Meyer, M. Rollinghoff, and C. Bogdan Inhibition of Inducible Nitric Oxide Synthase Exacerbates Chronic Cerebral Toxoplasmosis in Toxoplasma gondii-Susceptible C57BL/6 Mice But Does Not Reactivate the Latent Disease in T. gondii-Resistant BALB/c Mice J. Immunol., March 15, 1999; 162(6): 3512 - 3518. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Jankovic, T. A. Wynn, M. C. Kullberg, S. Hieny, P. Caspar, S. James, A. W. Cheever, and A. Sher Optimal Vaccination Against Schistosoma mansoni Requires the Induction of Both B Cell- and IFN-{gamma}-Dependent Effector Mechanisms J. Immunol., January 1, 1999; 162(1): 345 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Y. Denkers and R. T. Gazzinelli Regulation and Function of T-Cell-Mediated Immunity during Toxoplasma gondii Infection Clin. Microbiol. Rev., October 1, 1998; 11(4): 569 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bourguin, M. Moser, D. Buzoni-Gatel, F. Tielemans, D. Bout, J. Urbain, and O. Leo Murine Dendritic Cells Pulsed In Vitro with Toxoplasma gondii Antigens Induce Protective Immunity In Vivo Infect. Immun., October 1, 1998; 66(10): 4867 - 4874. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Silva, R. T. Gazzinelli, D. A. O. Silva, E. A. V. Ferro, L. H. Kasper, and J. R. Mineo Expression of Toxoplasma gondii-Specific Heat Shock Protein 70 during In Vivo Conversion of Bradyzoites to Tachyzoites Infect. Immun., August 1, 1998; 66(8): 3959 - 3963. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Dubey, D. S. Lindsay, and C. A. Speer Structures of Toxoplasma gondii Tachyzoites, Bradyzoites, and Sporozoites and Biology and Development of Tissue Cysts Clin. Microbiol. Rev., April 1, 1998; 11(2): 267 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Subauste, F. Fuh, R. de Waal Malefyt, and J. S. Remington {alpha}{beta} T Cell Response to Toxoplasma gondii in Previously Unexposed Individuals J. Immunol., April 1, 1998; 160(7): 3403 - 3411. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Deckert-Schluter, H. Bluethmann, A. Rang, H. Hof, and D. Schluter Crucial Role of TNF Receptor Type 1 (p55), But Not of TNF Receptor Type 2 (p75), in Murine Toxoplasmosis J. Immunol., April 1, 1998; 160(7): 3427 - 3436. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Yap, T. Scharton-Kersten, H. Charest, and A. Sher Decreased Resistance of TNF Receptor p55- and p75-Deficient Mice to Chronic Toxoplasmosis Despite Normal Activation of Inducible Nitric Oxide Synthase In Vivo J. Immunol., February 1, 1998; 160(3): 1340 - 1345. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Johnson and P. C. Sayles Interleukin-12, Dendritic Cells, and the Initiation of Host-protective Mechanisms against Toxoplasma gondii J. Exp. Med., December 1, 1997; 186(11): 1799 - 1802. [Full Text] [PDF] |
||||
![]() |
T. M. Scharton-Kersten, G. Yap, J. Magram, and A. Sher Inducible Nitric Oxide Is Essential for Host Control of Persistent but Not Acute Infection with the Intracellular Pathogen Toxoplasma gondii J. Exp. Med., April 7, 1997; 185(7): 1261 - 1274. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |